IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against CytRx
Corporation and Reminds Investors With Losses to Contact the Firm
Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against CytRx Corporation (“CytRx” or the
“Company”) (Nasdaq: CYTR). Investors who purchased or otherwise acquired shares between November 18, 2014 and July 11, 2016
inclusive (the “Class Period”), are encouraged to contact the Firm prior to the September 23, 2016 lead plaintiff motion
deadline.
If you purchased shares of CytRx during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von
Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may
choose to take no action and remain a passive class member.
According to the complaint, the Company made materially false and misleading statements and/or failed to disclose that: the
clinical hold placed on the Phase 3 trial of aldoxorubicin would prevent sufficient follow-up for patients involved in the study;
that almost half of the patients would be excluded from the progression free survival evaluation; CytRx would like conduct a second
analysis; that the results of the trial could be affected or approval of aldoxorubicin could be delayed; and that as a result of
the above, the Company’s statements were false and misleading and/or lacked a reasonable basis at all relevant times.
If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.
This press release may constitute Attorney Advertising in some jurisdictions.
Khang & Khang LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160726006579/en/